December 10, 2012 / 12:45 PM / 5 years ago

BRIEF-Zogenix drops in premarket after FDA panel recommendation

NEW YORK, Dec 10 (Reuters) - Zogenix Inc : * Drops 42 percent to $1.37 in premarket after a U.S. Food and Drug Administration panel of outside experts on Friday voted against recommending the company’s Zohydro painkiller for approval

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below